BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9187067)

  • 1. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
    Hartmann LC; Tschetter LK; Habermann TM; Ebbert LP; Johnson PS; Mailliard JA; Levitt R; Suman VJ; Witzig TE; Wieand HS; Miller LL; Moertel CG
    N Engl J Med; 1997 Jun; 336(25):1776-80. PubMed ID: 9187067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial.
    Lu W; Matulonis UA; Doherty-Gilman A; Lee H; Dean-Clower E; Rosulek A; Gibson C; Goodman A; Davis RB; Buring JE; Wayne PM; Rosenthal DS; Penson RT
    J Altern Complement Med; 2009 Jul; 15(7):745-53. PubMed ID: 19552597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy induced febrile neutropenia: management and prevention.
    Marshall E; Innes H
    Clin Med (Lond); 2008 Aug; 8(4):448-51. PubMed ID: 18724618
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy.
    Crawford J; Kreisman H; Garewal H; Jones SE; Shoemaker D; Pupa MR; Armstrong S; Tomita D; Dziem G
    Ann Oncol; 1997 Nov; 8(11):1117-24. PubMed ID: 9426331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidation.
    Pham L; Komalavilas P; Eddie AM; Thayer TE; Greenwood DL; Liu KH; Weinberg J; Patterson A; Fessel JP; Boyd KL; Schafer JC; Kuck JL; Shaver AC; Flaherty DK; Matlock BK; Wijers CDM; Serezani CH; Jones DP; Brittain EL; Rathmell JC; Noto MJ
    Commun Biol; 2022 Dec; 5(1):1366. PubMed ID: 36513703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study.
    Lamaj G; Pablo-Trinidad A; Butterworth I; Bell N; Benasutti R; Bourquard A; Sanchez-Ferro A; Castro-Gonzalez C; Jiménez-Ubieto A; Baumann T; Rodriguez-Izquierdo A; Pottier E; Shelton A; Martinez-Lopez J; Sloan JM
    J Med Internet Res; 2022 Aug; 24(8):e37368. PubMed ID: 35943786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria.
    Salako O; Okunade KS; Adeniji AA; Fagbenro GT; Afolaranmi OJ
    Ecancermedicalscience; 2021; 15():1188. PubMed ID: 33777181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an improved murine model of necrotizing enterocolitis shows the importance of neutrophils in NEC pathogenesis.
    Klinke M; Vincent D; Trochimiuk M; Appl B; Tiemann B; Reinshagen K; Pagerols Raluy L; Boettcher M
    Sci Rep; 2020 May; 10(1):8049. PubMed ID: 32415172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.
    Abdel-Azim H; Sun W; Wu L
    Pharmacol Ther; 2019 Dec; 204():107403. PubMed ID: 31470030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in short-term risk of rejection in heart transplant patients receiving granulocyte colony-stimulating factor.
    Nguyen AB; Lourenço L; Chung BB; Imamura T; Rodgers D; Besser SA; Murks C; Riley T; Powers J; Raikhelkar J; Kalantari S; Sarswat N; Jeevanandam V; Kim G; Sayer G; Uriel N
    J Heart Lung Transplant; 2018 Nov; 37(11):1322-1328. PubMed ID: 30174163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequate Neutrophil Responses and Non-Inferior Clinical Outcomes Can Be Achieved by a Two-Day Course of Low-Dose Filgrastim: A Retrospective Single Institution Experience.
    Singh R; Heisey H; Elsayed AG; Tirona MT
    Cureus; 2017 Dec; 9(12):e1968. PubMed ID: 29492357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Choosing wisely recommendations in hematology and oncology].
    Krause SW; Neubauer A
    Internist (Berl); 2017 Jun; 58(6):545-549. PubMed ID: 28497377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size.
    Kiafar F; Siahi Shadbad MR; Valizadeh H
    Bioimpacts; 2016; 6(4):195-201. PubMed ID: 28265535
    [No Abstract]   [Full Text] [Related]  

  • 14. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality.
    Li L; Qi X; Sun W; Abdel-Azim H; Lou S; Zhu H; Prasadarao NV; Zhou A; Shimada H; Shudo K; Kim YM; Khazal S; He Q; Warburton D; Wu L
    EMBO Mol Med; 2016 Nov; 8(11):1340-1359. PubMed ID: 27737899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
    Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey.
    Sakai H; Katsumata N; Kadokura G
    BMC Cancer; 2015 Oct; 15():651. PubMed ID: 26438185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.
    Cortés de Miguel S; Calleja-Hernández MÁ; Menjón-Beltrán S; Vallejo-Rodríguez I
    Support Care Cancer; 2015 Feb; 23(2):547-59. PubMed ID: 25284722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence.
    Vasin MV
    Springerplus; 2014; 3():414. PubMed ID: 25133093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.
    Liongue C; Ward AC
    Front Oncol; 2014; 4():93. PubMed ID: 24822171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan.
    Harano K; Hirakawa A; Kato T; Suzuki K; Watanabe S; Katsumata N
    J Gynecol Oncol; 2014 Apr; 25(2):124-9. PubMed ID: 24761216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.